Personalized breast cancer screening based on individual risk factors
Extending the Diversity, Reach, and Generalizability of the WISDOM Study
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10798287
This study is looking at a new way to screen for breast cancer that’s customized for each woman based on her individual risk, and it wants to see how this personalized approach compares to the usual yearly screenings, all while including women from different backgrounds to make sure the results are helpful for everyone.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10798287 on ClinicalTrials.gov |
What this research studies
This research investigates a personalized approach to breast cancer screening, where the frequency and method of screening are tailored to each woman's specific risk profile. The study aims to compare this personalized method with the traditional annual screening to assess safety, acceptance, and overall health outcomes. By expanding the study to include diverse populations across the country, the researchers hope to enhance the generalizability of their findings and improve screening practices. The project also involves collaboration with various insurance providers to reach a broader demographic of women.
Who could benefit from this research
Good fit: Ideal candidates for this research are women of varying ages and backgrounds who are at risk for breast cancer and are interested in personalized screening options.
Not a fit: Patients who are not at risk for breast cancer or those who prefer traditional screening methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized breast cancer screening strategies that improve health outcomes for women.
How similar studies have performed: Previous research has shown promise in personalized screening approaches, indicating potential for success in this expanded study.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ESSERMAN, LAURA J — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: ESSERMAN, LAURA J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Breast Cancer, Cancers